List of Tables
Table 1. Global Targeted Antitumor Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Targeted Antitumor Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Targeted Antitumor Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Targeted Antitumor Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Targeted Antitumor Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Targeted Antitumor Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Targeted Antitumor Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Targeted Antitumor Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Targeted Antitumor Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Targeted Antitumor Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Targeted Antitumor Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Targeted Antitumor Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Antitumor Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Antitumor Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Targeted Antitumor Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Targeted Antitumor Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Targeted Antitumor Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Targeted Antitumor Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Targeted Antitumor Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Targeted Antitumor Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Targeted Antitumor Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Targeted Antitumor Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Targeted Antitumor Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Targeted Antitumor Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Targeted Antitumor Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Targeted Antitumor Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Targeted Antitumor Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Targeted Antitumor Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Targeted Antitumor Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Targeted Antitumor Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Targeted Antitumor Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Targeted Antitumor Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Targeted Antitumor Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Targeted Antitumor Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Targeted Antitumor Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Targeted Antitumor Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Targeted Antitumor Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Targeted Antitumor Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Targeted Antitumor Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Targeted Antitumor Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Targeted Antitumor Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Targeted Antitumor Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Targeted Antitumor Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Targeted Antitumor Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Targeted Antitumor Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Targeted Antitumor Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Targeted Antitumor Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Targeted Antitumor Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Targeted Antitumor Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Targeted Antitumor Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Targeted Antitumor Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Targeted Antitumor Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Targeted Antitumor Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Targeted Antitumor Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Targeted Antitumor Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Targeted Antitumor Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Targeted Antitumor Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Targeted Antitumor Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Targeted Antitumor Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Targeted Antitumor Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Targeted Antitumor Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Targeted Antitumor Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Targeted Antitumor Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Targeted Antitumor Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Targeted Antitumor Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Targeted Antitumor Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Targeted Antitumor Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Targeted Antitumor Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Targeted Antitumor Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Celgene Company Information
Table 76. Celgene Description and Business Overview
Table 77. Celgene Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Celgene Targeted Antitumor Drugs Product
Table 79. Celgene Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Targeted Antitumor Drugs Product
Table 84. Novartis Recent Developments/Updates
Table 85. Johnson & Johnson Company Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Johnson & Johnson Targeted Antitumor Drugs Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Lilly Company Information
Table 91. Lilly Description and Business Overview
Table 92. Lilly Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Lilly Targeted Antitumor Drugs Product
Table 94. Lilly Recent Developments/Updates
Table 95. AstraZeneca plc. Company Information
Table 96. AstraZeneca plc. Description and Business Overview
Table 97. AstraZeneca plc. Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca plc. Targeted Antitumor Drugs Product
Table 99. AstraZeneca plc. Recent Developments/Updates
Table 100. Betta Pharmaceuticals Company Information
Table 101. Betta Pharmaceuticals Description and Business Overview
Table 102. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Betta Pharmaceuticals Targeted Antitumor Drugs Product
Table 104. Betta Pharmaceuticals Recent Developments/Updates
Table 105. Shanghai Henlius Biopharmaceutical Company Information
Table 106. Shanghai Henlius Biopharmaceutical Description and Business Overview
Table 107. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product
Table 109. Shanghai Henlius Biopharmaceutical Recent Developments/Updates
Table 110. Innovent Biologics Company Information
Table 111. Innovent Biologics Description and Business Overview
Table 112. Innovent Biologics Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Innovent Biologics Targeted Antitumor Drugs Product
Table 114. Innovent Biologics Recent Developments/Updates
Table 115. Nanjing Shunxin Pharmaceuticals Company Information
Table 116. Nanjing Shunxin Pharmaceuticals Description and Business Overview
Table 117. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product
Table 119. Nanjing Shunxin Pharmaceuticals Recent Developments/Updates
Table 120. CSPC OUYI Pharmaceutical Company Information
Table 121. CSPC OUYI Pharmaceutical Description and Business Overview
Table 122. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product
Table 124. CSPC OUYI Pharmaceutical Recent Developments/Updates
Table 125. Qilu Pharmaceutical Company Information
Table 126. Qilu Pharmaceutical Description and Business Overview
Table 127. Qilu Pharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Qilu Pharmaceutical Targeted Antitumor Drugs Product
Table 129. Qilu Pharmaceutical Recent Developments/Updates
Table 130. Shenzhen Salubris Pharmaceuticals Company Information
Table 131. Shenzhen Salubris Pharmaceuticals Description and Business Overview
Table 132. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product
Table 134. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
Table 135. Yaopharma Company Information
Table 136. Yaopharma Description and Business Overview
Table 137. Yaopharma Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Yaopharma Targeted Antitumor Drugs Product
Table 139. Yaopharma Recent Developments/Updates
Table 140. Lianyungang Runzhong Pharmaceutical Company Information
Table 141. Lianyungang Runzhong Pharmaceutical Description and Business Overview
Table 142. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product
Table 144. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Targeted Antitumor Drugs Distributors List
Table 148. Targeted Antitumor Drugs Customers List
Table 149. Targeted Antitumor Drugs Market Trends
Table 150. Targeted Antitumor Drugs Market Drivers
Table 151. Targeted Antitumor Drugs Market Challenges
Table 152. Targeted Antitumor Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted Antitumor Drugs
Figure 2. Global Targeted Antitumor Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Antitumor Drugs Market Share by Type: 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Targeted Antitumor Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Targeted Antitumor Drugs Market Share by Application: 2024 & 2031
Figure 9. Lung Cancer
Figure 10. Lymphoma
Figure 11. Breast Cancer
Figure 12. Leukaemia
Figure 13. Prostate Cancer
Figure 14. Multiple Bone Marrow Cancer
Figure 15. Others
Figure 16. Global Targeted Antitumor Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Targeted Antitumor Drugs Market Size (2020-2031) & (US$ Million)
Figure 18. Global Targeted Antitumor Drugs Sales (2020-2031) & (K Units)
Figure 19. Global Targeted Antitumor Drugs Average Price (US$/Unit) & (2020-2031)
Figure 20. Targeted Antitumor Drugs Report Years Considered
Figure 21. Targeted Antitumor Drugs Sales Share by Manufacturers in 2024
Figure 22. Global Targeted Antitumor Drugs Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Targeted Antitumor Drugs Players: Market Share by Revenue in Targeted Antitumor Drugs in 2024
Figure 24. Targeted Antitumor Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Targeted Antitumor Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Targeted Antitumor Drugs Sales Market Share by Country (2020-2031)
Figure 27. North America Targeted Antitumor Drugs Revenue Market Share by Country (2020-2031)
Figure 28. United States Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Targeted Antitumor Drugs Sales Market Share by Country (2020-2031)
Figure 31. Europe Targeted Antitumor Drugs Revenue Market Share by Country (2020-2031)
Figure 32. Germany Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Targeted Antitumor Drugs Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Targeted Antitumor Drugs Revenue Market Share by Region (2020-2031)
Figure 39. China Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Targeted Antitumor Drugs Sales Market Share by Country (2020-2031)
Figure 47. Latin America Targeted Antitumor Drugs Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Targeted Antitumor Drugs Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Targeted Antitumor Drugs Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Targeted Antitumor Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Targeted Antitumor Drugs by Type (2020-2031)
Figure 57. Global Revenue Market Share of Targeted Antitumor Drugs by Type (2020-2031)
Figure 58. Global Targeted Antitumor Drugs Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Targeted Antitumor Drugs by Application (2020-2031)
Figure 60. Global Revenue Market Share of Targeted Antitumor Drugs by Application (2020-2031)
Figure 61. Global Targeted Antitumor Drugs Price (US$/Unit) by Application (2020-2031)
Figure 62. Targeted Antitumor Drugs Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
